Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PVC2 | ISIN: KYG4783B1032 | Ticker-Symbol: 33C
Stuttgart
21.11.24
08:09 Uhr
0,800 Euro
0,000
0,00 %
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
INNOCARE PHARMA LTD Chart 1 Jahr
5-Tage-Chart
INNOCARE PHARMA LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,7550,83015:22
0,7550,83015:19

Aktuelle News zur INNOCARE PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.11.INNOCARE 1-3Q24 Loss Narrows to RMB275M2
11.11.INNOCARE (09969): 2024 QUARTERLY REPORT FOR THE THIRD QUARTER AND UPDATE IN USE OF PROCEEDS-
28.10.INNOCARE (09969): DATE OF BOARD MEETING2
09.10.InnoCare's TYK2 inhibitor shows potential to rival Sotyktu in Chinese phase 2 psoriasis trial1
09.10.INNOCARE (09969): VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL STUDY OF ICP-488 FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS MET PRIMARY ENDPOINT-
25.09.INNOCARE (09969): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS-
25.09.INNOCARE (09969): (1) RESIGNATION OF NON-EXECUTIVE DIRECTOR (2) RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND (3) CHANGE IN COMPOSITION OF BOARD ...-
INNOCARE PHARMA Aktie jetzt für 0€ handeln
24.09.INNOCARE (09969): INTERIM REPORT 20241
29.08.INNOCARE (09969): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARE CAPITAL-
20.08.InnoCare Pharma says total revenue reached RMB419.7M in the first half of 20241
20.08.InnoCare Releases 2024 Interim Results and Business Highlights443BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2024 interim results and...
► Artikel lesen
20.08.INNOCARE (09969): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024-
07.08.INNOCARE (09969): DATE OF BOARD MEETING1
18.07.INNOCARE (09969): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARE CAPITAL2
28.06.INNOCARE (09969): GRANT OF RESTRICTED SHARE UNITS PURSUANT TO 2023 SHARE AWARD SCHEME2
27.06.INNOCARE (09969): FIFTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION2
27.06.INNOCARE (09969): POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 27 JUNE 20241
20.06.INNOCARE (09969): VOLUNTARY ANNOUNCEMENT - BIOLOGICS LICENSE APPLICATION FOR TAFASITAMAB IN COMBINATION WITH LENALIDOMIDE FOR THE TREATMENT OF RELAPSED ...2
31.05.INNOCARE (09969): VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING OF THE COMPANY BY THE CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR1
30.05.INNOCARE (09969): GRANT OF RESTRICTED SHARES PURSUANT TO 2023 RMB SHARE INCENTIVE SCHEME1
Seite:  Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1